228 / 1498
Age (yrs)
Relative risks of SMN by age at HL diagnosis
•
International cohort study: 32,591 HL patients
•
1,111 25-years survivors, population-based
0,0
2,0
4,0
6,0
8,0
10,0
12,0
14,0
16,0
All solid
Breast
Lung
GI tract
Relative Risk
<21
21-30
31-40
41-50
51-60
>=61
0,0
5,0
10,0
15,0
20,0
25,0
30,0
35,0
4 ,0
45,0
All solid
Breast
Lung
GI tract
ANLL
Relative Risk
<21
21-30
31-40
41-50
51-60
>=61